Delivery Order SPE2DB22D2206-SPE2DB25FGG07

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,191.34, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,682.92, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through November 21, 2024. This delivery order is part of a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,312.98, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,226.54, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,541.93, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a medical product, and has a completion date of March 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $32,727.00, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a period of performance through February 25, 2025 and uses a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,409.13 fixed-price contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of January 5, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.35, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML medical supplies. The contract has a fixed price and is set to run through February 20, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,433.55, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication. The contract is a firm fixed-price type with an ultimate completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,015.13, is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGG07
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,609.54, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a prescription medication. The contract is a firm fixed-price delivery order with a period of performance ending on March 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/24/25, 9:56 AM